Ornella Argento
Overview
Explore the profile of Ornella Argento including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bossa M, Manocchio N, Argento O
NeuroSci
. 2024 Nov;
3(3):476-493.
PMID: 39483435
Cognitive impairment (CI) represents a common symptom in patients suffering from multiple sclerosis (MS), which can affect every stage of the disease course. Recent studies seem to support cognitive rehabilitation...
2.
Argento O, Piacentini C, Bossa M, Caltagirone C, Santamato A, Saraceni V, et al.
NeuroSci
. 2024 Nov;
3(3):395-407.
PMID: 39483428
MS clinical features vary between patients. In approximately 60% of cases, cognitive deficits are associated with motor disabilities, with consequences on both walking and maintaining balance and cognitive efficiency. Multimodal...
3.
Tramontano M, Argento O, Manocchio N, Piacentini C, Orejel Bustos A, De Angelis S, et al.
J Clin Med
. 2024 May;
13(9).
PMID: 38731193
Recent studies underscore the intricate relationship between cognitive and motor impairments in Multiple Sclerosis (MS), often exacerbated by CNS damage compromising neural connections. These cognitive-motor deficits contribute to reduced efficiency...
4.
Tramontano M, Argento O, Orejel Bustos A, De Angelis S, Montemurro R, Bossa M, et al.
Eur J Phys Rehabil Med
. 2023 Nov;
60(1):27-36.
PMID: 37997324
Background: Multiple Sclerosis (MS) is a chronic inflammatory, demyelinating, degenerative disease of the central nervous system and the second most frequent cause of permanent disability in young adults. One of...
5.
Bossa M, Argento O, Piacentini C, Manocchio N, Scipioni L, Oddi S, et al.
Brain Sci
. 2023 Aug;
13(8).
PMID: 37626494
-palmitoylethanolamine (PEA) plays a key role in preventing Aβ-mediated neuroinflammation and neurotoxicity in murine models. It has been demonstrated that PEA provides anti-neuroinflammatory, pain-relieving and neuroprotective actions even in humans....
6.
Piacentini C, Argento O, Nocentini U
Arq Neuropsiquiatr
. 2023 Jun;
81(6):585-596.
PMID: 37379870
Multiple sclerosis (MS) is a central nervous system (CNS) disease characterized by inflammation, axonal demyelination, and neurodegeneration, which can have a strong impact on all aspects of the life of...
7.
Argento O, Piacentini C, Bossa M, Caltagirone C, Santamato A, Saraceni V, et al.
Neurol Sci
. 2023 Jan;
44(5):1835.
PMID: 36658412
No abstract available.
8.
Argento O, Piacentini C, Bossa M, Nocentini U
Int J Environ Res Public Health
. 2022 Dec;
19(24).
PMID: 36554293
(1) Background: Emotional recognition (ER), the ability to read into others' minds and recognize others' emotional states, is important in social environment adaptation. Recently it has been found that ER...
9.
Argento O, Piacentini C, Bossa M, Caltagirone C, Santamato A, Saraceni V, et al.
Neurol Sci
. 2022 Dec;
44(3):1109-1118.
PMID: 36542204
Background: At the moment, the possible options for the management of cognitive dysfunctions in patients with MS (pMS) are pharmacological interventions, cognitive rehabilitation (CR), and physical exercise. However, worldwide, multimodal...
10.
DellErba S, Melissano P, Zegretti A, Paniccia M, Marri M, Caruso M, et al.
Pediatr Int
. 2022 Dec;
65(1):e15449.
PMID: 36529639
Background: The aim of the study was to compare psychological characteristics of adolescent patients with juvenile fibromyalgia syndrome (JFM) with individuals suffering from chronic pain (CP) due to headache or...